When was Fengkai Medical Devices founded?

Fengkai Medical Devices was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Where is Fengkai Medical Devices located?

Fengkai Medical Devices is headquartered in Shanghai, China.

Who is the current CEO of Fengkai Medical Devices?

Zhirong Tang of Fengkai Medical Devices. They have also founded 1 company.

Is Fengkai Medical Devices a funded company?

Fengkai Medical Devices is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Sep 30, 2021.

When was the latest funding round of Fengkai Medical Devices?

Fengkai Medical Devices' latest funding was a $***** Series B round on Sep 30, 2021, with participation from 6 investors.

Where does Fengkai Medical Devices rank among its competitors?

Fengkai Medical Devices ranks 58th amongst 96 active competitors, of which 58 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was FineHeart, which secured $40.8M in Jan, 2026.

Who are the top competitors of Fengkai Medical Devices?

Fengkai Medical Devices' top competitors include CVRx, Adona Medical and Impulse Dynamics. Among them, FineHeart secured the most recent funding round in January, 2026.

Fengkai Medical Devices - 2026 Company Profile, Team, Funding & Competitors

Fengkai Medical Devices is a series B company based in Shanghai (China), founded in 2015 by Zhirong Tang. It operates as a Developer of a therapeutic device to treat patients with heart failure. Fengkai Medical Devices has raised an undisclosed amount in funding from Legend Capital. The company has 96 active competitors, including 58 funded and 13 that have exited. Its top competitors include companies like CVRx, Adona Medical and Impulse Dynamics.

Company Details

Developer of a therapeutic device to treat patients with heart failure. The company has developed Cardiac Flow a Percutaneous Ventricular Assist System which consists of a catheter pump, and an external controller to treat patients with cardiogenic shock.

Website: www.forqaly.com
Email ID: *****@forqaly.com
Phone Number: +86 **********

Key Metrics

Founded Year

2015

Location

Shanghai, China

Stage

Series B

Latest Funding Round

Series B, Sep 30, 2021, $*****

Investors

Legend Capital & 6 more

Ranked

58^th among 96 active competitors

Similar Companies

CVRx & 122 more

View Fengkai Medical Devices' full profile

Fengkai Medical Devices has raised funding over 1 round. Its latest funding round was a Series B round on Sep 30, 2021 for $*****. 6 investors participated in its latest round. Fengkai Medical Devices has 7 institutional investors.

Here is the list of recent funding rounds of Fengkai Medical Devices:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2021	8967783	Series B	3709478	9006231	5872427	4215856

Access funding benchmarks and valuations. Sign up today!

View details of Fengkai Medical Devices's funding rounds and investors

The founders of Fengkai Medical Devices is Zhirong Tang. Zhirong Tang is the CEO of Fengkai Medical Devices.

Here are the details of Fengkai Medical Devices' key team members:

Zhirong Tang: Founder & CEO of Fengkai Medical Devices.

View details of Fengkai Medical Devices's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Fengkai Medical Devices include CVRx, Adona Medical and Impulse Dynamics. Here is the list of Top 10 competitors of Fengkai Medical Devices, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CVRx 2001, Minneapolis (United States), Public	Developer of implantable technology for hypertension and heart failure	$394M	Johnson & Johnson Innovation – JJDC, New Enterprise Associates ... & 20 others	68/100
2nd	Adona Medical 2017, Campbell (United States), Series C	Developer of medical devices for the management of heart failure	$71M	Cormorant Asset Management, The Capital Partnership ... & 7 others	65/100
3rd	Impulse Dynamics 1998, Marlton (United States), Series F	Provider of implantable device for treatment of chronic heart failure	$685M	Sands Capital, Perceptive Advisors & 16 others	64/100
4th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100
5th	SynCardia 2001, Tucson (United States), Public	Artificial heart	$72M	Athyrium Capital Management, SWK Holdings ... & 5 others	60/100
6th	Corvia Medical 2009, Tewksbury (United States), Acquired	Developer of transcatheterally shunt for treating diastolic heart failure disease	$160M	Edwards Lifesciences, Accelmed & 4 others	60/100
7th	Reprieve Cardiovascular 2018, Milford (United States), Series B	Developer of decongestion management solution for acute decompensated heart failure patients	$150M	Deerfield, Arboretum Ventures & 8 others	58/100
8th	Restore Medical 2016, Tel Aviv (Israel), Series B	Catheter-delivered implant for treatment of congestive heart failure	$32M	Pitango, European Innovation Council & 3 others	58/100
9th	InterShunt Technologies 2015, Louisiana (United States), Series B	Developer of cardiac catheter for the treatment of cardiac diseases	$26.6M	Solas BioVentures, Gener8tor & 6 others	57/100
10th	FineHeart 2010, Pessac (France), Series C	Developer of an implantable cardiovascular device for treating heart failures	$51.9M	Verve Ventures, Broadview Ventures & 16 others	57/100
58th	Fengkai Medical Devices 2015, Shanghai (China), Series B	Developer of a therapeutic device to treat patients with heart failure	-	CD Capital, Legend Capital & 5 others	30/100